Billionaire Eric Lefkofsky’s new company Tempus has gained around $80 million in new funding from its investors. The Chicago-based Tempus was founded as a startup in 2015 as a technology-based company that helps personalize cancer treatment based on data. The latest investments bringing the total since the company was founded to around $210 million. This makes the company worth in excess of $1.1 billion.
Tempus currently has just a over 400 employees in the Chicago area and has been increasing at a rate of around 30 each month. Eric Lefkofsky plans for that pace to continue as Tempus attempts to grow its reach across the U.S. and the world. The value and size of the company means that it has now achieved “unicorn” status, something that not many startups have the distinction of having.
Tempus uses data in order to customized treatment plans for cancer patients in hopes of making the treatments more effective and efficient. The clinical and molecular data is collected and used to find potential trends in cancer treatment as well as help doctors and patients communicate more effectively.
Eric Lefkofsky is proud of the company and the relationships its has in the health car industry, from doctors to pharmaceutical companies. He says that the data side of his business and how it can help enhance cancer treatment is shifting the way in which cancer treatment is being seen among those in the healthcare community.
The $80 million investment in Tempus came from many individuals and companies to include previous investors, New Enterprise Associates and Revolution Growth. New investors in Tempus include T. Rowe Price Associates funds and the Kinship Trust Company. The new and existing investors will help Tempus grow their operations and help them reach more doctors and patients. This increase in data will further help the company find more innovative solutions for the treatment of cancers.
Eric Lefkofsky co-founded Tempus Labs in 2015 which is a technology firm. The goal of the company is to digitize, merge, consolidate, and clean up the information gathered on each cancer patient in order to make it easier for physicians to assist future patients.
The ultimate goal is to gather molecular data of each patient in one location so that physicians can make decisions based on data. This data is vital to learning from patients who have cancer and from their treatments and responses so that future patients can receive the best care possible from physicians making the best decisions that they possibly can.
Alzheimer’s is just one disease that can greatly benefit from big data and because of this, patients are able to become enrolled in studies much more quickly. With many diseases, and especially with Alzheimer’s in particular, it is better to receive treatment sooner than later.
In many cases, almost 30 percent of cases that are being studied, do not actually have Alzheimer’s but have other types of dementia or even completely different medical conditions. Patients under study with pre-symptomatic conditions are of great help in finding out more about this particular disease as well as others.
Tempus has already made a name for itself and is one of the top ten health techs in Chicago. The company has partnerships with multiple organizations as well as many Comprehensive Cancer Centers. Because of that, they receive may patients that need genomic sequencing. They make it possible for physicians to find any mutations that may be present and can find the best treatment options to proceed with.
Eric Lefkofsky graduated from the University of Michigan and holds a Juris Doctor which he received from the University of Michigan Law School. He also established the Lefkofsky Family Foundation and serves as trustee of Lurie Children’s Hospital located in Chicago as well as The Art Institute, Museum of Science and Industry and World Business also all located in Chicago. Lefkofsky is also a professor at the University of Chicago as well as the author of a book called Accelerated Disruption.
Now, individuals can learn more about CTCA’s latest cancer news online via WebMD. Cancer Treatment Centers of America proudly launched their brand new cancer education method just recently. There already are a number of factual and compelling WebMD articles about specific cancer and related topics. More is soon to follow. CTCA staff realize that cancer patients and their frightened families want and deserve answers to some hard to ask cancer questions that eventually tends to come up. CTCA is offering another more convenient way to gain understanding of some cancer related developments in care, treatment choices, new supportive measures and cancer research results.
Cancer patients are relieved to know that they have an easy and private way in which they can look up cancer related subjects. More patients do turn to the Internet when a question related to health needs answered. There is no long wait for an appointment time, and no travel required to find the answers when patients look for common cancer answers while online. WebMD certainly sees a lot of traffic every day. Now, with a collaborative education effort between this well liked health online site and Cancer Treatment Centers of America, things just became even easier and better.
Patients know that they can rely on the information gleaned from both Cancer Treatment Centers of America websites and now WebMD too. The amount of information that patients can take in while browsing the Internet tends to be much higher than when patients are in medical settings speaking to healthcare experts. People tend to be more relaxed when researching their healthcare questions online. This is a major part of the many beneficial reasons that CTCA and WebMD has launched this brand new health education collaboration. WebMD articles are regarded highly among the public, and individuals can understand the common day language that the site tries to use in explaining health related things.
Learning more about cancer can increase survival rates drastically as knowledgeable patients will tend to search for help quicker. The sooner cancer treatments are started, the better the chances for full remission. This is also why CTCA is adamant regarding the continuation and future planned improvements in the way this cancer treatment center delivers its informative cancer education to those who really need it. Online learning has gained many followers, and online learning experts feel that this method can even be more fruitful for some individuals.
When someone is battling with cancer, the only thing that they want to do is live. With their will power and other means, they may be able to beat it. In many cases, they may need the assistance of professionals that can help them. The Cancer Treatment Centers of America are there to help them along the way.
People that go to the Cancer Treatment Centers of America are surrounded by good and caring people at all times. They are educated, trained professionals that are always interested in ways to help those that are afflicted with disease of cancer. They are able to assist them in many ways. With their positive influence, they can set up a program that deals with both the medical and emotional aspects of healing people that are sick.
Cancer is horrible disease that has taken many lives. People need to know that they can find help at the Cancer Treatment Centers of America so that they can get the assistance that they need. It can make all the difference in their lives.
With the many ways that the Cancer Treatment Centers of America can help, a person can feel that they are among people that care about them to the highest level. This can make huge difference for them as they fight their toughest battle of their life. Since they will need the help of loved ones too, this is also considered at the Cancer Treatment Centers of America. Family and loved ones are encouraged to take part in the daily caring of their loved one.
The Cancer Treatment Center Of America has partnered with two very popular medical networks to bring superior research to oncology and help cancer suffers around the world live a better life during their treatment and remission. In fact, they work closely with Nanthealth and Allscripts to launch clinical pathway research and the transformation of traditional cancer treatment methods. Their electronic health records will help improve the treatment process by minimize the amount of necessary workflow. The have a list of the most comprehensive cancer data in the country and continue to be the leaders in cancer research and improving every facet of the debilitating illness.
They have a curated list of superior protocol for thousands of patients worldwide. They have integrated the last interactive technology features designed with their patients in mind. Chief Medical Officer of CTCA, Dr. George Daneker says, it takes the guesswork out of new data and oncology. They handle the direct operating system of all of their research data, treatment, and more. Specialist have said they need revolving solution to the way data is stored and collected on their patients to aid in their treatment and recovery at Cancer Treatment Centers Of America.
They work hard to give their patients the best shot at recovery while reducing the work load of their staff to focus on the patients and never lose focus of the patients they’re fighting for. They use advanced technologies and work hard for everyone who walks through their doors.
Cancer is one of the many diseases that seems to be running rampant throughout our society today. Many of the different forms of cancer has potentiality ratings of 1 out of 3 or 1 out of 5 are predicted to be diagnosed with this or that form of cancer. Prostate cancer is no different and can, in fact, be even sneakier. It is very common for men to be either too prideful or too embarrassed to undergo the process of prostate examination to check for cancer. Let’s face it; it is not a comfortable occasion on a range of levels.
The NFLA, National Football League Alumni Association, Cancer Treatment Centers of America and LabCorp have partnered up to help spread awareness as well as offering free prostate exams to over 2,000 males who meet eligibility requirements.
These screenings are being offered at a reduces rate to any men who sign up to have a Prostate Specific Antigen screening at any one of LabCorp’s 1,750 locations across the nation. The free exam window has elapsed as of this article’s writing date but the partnership of these amazing companies is still offering these prostate screenings for an amazingly low price of $25.
With this level of awareness spreading, there is simply no excuse to not have the exam performed. Many men will needlessly loose a battle to prostate cancer, a battle that may have been won if it had been discovered early enough.
Cancer Treatment Centers of America are cancer treatment facilities that originally were founded in 1988 after founder, Richard J. Stephenson’s mother passed away after losing a battle with cancer. Richard started the Cancer Treatment Centers of America because he felt that his mother simply did not get the best level of care possible and thought no one should have to go through what he did.
The recent increase in the number of patients and population aging and growth in America has increased health care charges. Furthermore, a new JAMA publication analysis indicated that a slight reduction in annual expenditure caused a shift in disease prevalence while the frequency of accessing healthcare services was constant. This is normal in America since this analysis denoted disease’s spending break down.
The analysis illustrated that different diseases have different factors causing the major increase. Diabetes portrayed the greatest yearly spending increase. This was due to population aging growth, price and utilization of pharmaceuticals diabetes prevalence. Despite attempts to minimize the rise in health care spending, the outpatient’s annual spending for all diseases increased. This was attributed to shorter hospital stays that offered packed care in fewer days at higher charges. It further stated that preventing hospitalizations due to high prices of drugs least increased health care spending. This research is important in the future and is subject to improvement.
The American entrepreneur, Eric Lefkofsky, was born on September 2, 1969. Mr. Lefkofsky is the co-founder and chief executive officer of Tempus, the co-founder of Echo Global Logistics, Lightbank, Mediaocean, Inner Workings and the chairman and co-founder of Groupon. He graduated with a bachelor’s degree in Law from the University of Michigan. Lefkofsky started his career as a carpet seller and later purchased Brandon Apparel. He co-founded Satrbelly, an internet company in 1990 to deal in promotional products.
In 2006, Mr. Lefkofsky and his wife founded the Lefkofsky Foundation with the aim of aiding children-based, charitable, educational and scientific organizations. The Lefkofsky Foundation has donated millions of dollars to Tempus. Tempus, co-founded by Lefkofsky, assists healthcare professionals and doctors develop personalized, data-driven and real-time treatment decisions though patients’ genetic code analysis. It uses the analysis method and cutting-edge demonic sequencing while aiding doctor understanding on patient’s tumor. This is why it works on patients with lung, pancreatic and breast cancer. Notably, Tempus is motivated at caring for loved ones and cancer patients than money.